
Eli Lilly Launches weight-loss drug Mounjaro in India
With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide), a once-weekly injectable drug for chronic weight management and type 2 diabetes. Approved by the Central Drugs …